Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Top Cited Papers
- 15 May 2010
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 31 (8), 1275-1283
- https://doi.org/10.1016/j.neurobiolaging.2010.04.007
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Molecular polymorphism of Aβ in Alzheimer's diseaseNeurobiology of Aging, 2010
- Absence of Pittsburgh Compound B Detection of Cerebral Amyloid β in a Patient With Clinical, Cognitive, and Cerebrospinal Fluid Markers of Alzheimer DiseaseArchives of Neurology, 2009
- Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's diseaseProceedings of the National Academy of Sciences, 2009
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the ElderlyArchives of Neurology, 2008
- Burden of Alzheimer's Disease: Population-Based Estimates and Projections for New Zealand, 2006–2031Australian & New Zealand Journal of Psychiatry, 2008
- Biomarkers for Early Detection of Alzheimer PathologyNeurosignals, 2007
- PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosisBrain, 2007
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Predictive Value of APOE Genotyping in Incipient Alzheimer's DiseasesaAnnals of the New York Academy of Sciences, 1996
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984